Lv1
10 积分 2024-02-18 加入
HER2-low breast cancers: Current insights and future directions
3小时前
已完结
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles
4个月前
已完结
HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis
6个月前
已完结
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets
10个月前
已完结
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond
11个月前
已完结
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer
11个月前
已完结
HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis
1年前
已完结
Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
1年前
已完结
‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study
1年前
已完结
ERBB2-Low Breast Cancer—Is It a Fact or Fiction, and Do We Have the Right Assay?
1年前
已完结
皖公网安备34019202002308
